BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SILCOPHL

All Eps Dividend Board Agm Q1 Q2 Q3

SILCOPHL 26-Nov-2020

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 29.11.2020 to 30.11.2020. Trading of the shares of the Company will remain suspended on record date i.e., 01.12.2020.

SILCOPHL 16-Nov-2020

(Continuation news of SILCOPHL): on the certainty of the balance available Tk.6,254,023/- shown in the Statement of Financial Position as at 30th June, 2020. The adjusted current year Tk. 6,380,888/-(Note:14) should have been made through banking channel. The company made cash payments which are not recommended by the relevant regulation. It was hard for us to reconcile the actual payment made by the company from WPPF fund during the year under audit. (end)

SILCOPHL 16-Nov-2020

The auditor of the Silco Pharmaceuticals Limited has given the " Emphasis of Matter " paragraph in the Auditor 's Report for the year ended on 30 June 2020. Emphasis of Matter: We draw attention to note number 2.15 (b) and 14 to the Financial Statements regarding contribution to provision for Employees Profit Participation Fund (WPPF) in accordance with Bangladesh Labour Act, 2006(Amended-2013) and subsequent payment to beneficiaries of the fund. We emphasize (cont.)

SILCOPHL 16-Nov-2020

(Q1 Un-audited): EPS was Tk. 0.33 for July-September 2020 as against Tk. 0.28 for July-September 2019; NOCFPS was Tk. 0.52 for July-September 2020 as against Tk. 0.41 for July-September 2019. NAV per share was Tk. 21.97 as on September 30, 2020 and Tk. 21.64 as on June 30, 2020.

SILCOPHL 02-Nov-2020

Dividend Declaration (Additional Information): The Company has further informed that the Sponsors and Directors hold 40,608,370 shares out of total 103,807,000 shares of the Company and the cash dividend to be payable to the General shareholders is BDT. 6,31,98,630.00.

SILCOPHL 02-Nov-2020

There will be no price limit on the trading of the shares of the Company today (02.11.2020) following its corporate declaration, however, as per the BSEC Order No. BSEC/CMRRCD/2001-07/04 dated March 19, 2020, the floor price shall be applicable accordingly.

SILCOPHL 02-Nov-2020

The Board of Directors has recommended 10% cash dividend (for all shareholders excluding Sponsors and Directors) for the year ended on June 30, 2020. Date of AGM: 24.12.2020, Time: 11:30 AM, Venue: Digital Platform. Record Date: 01.12.2020. The Company has reported EPS of Tk. 0.80, NAV per share of Tk. 21.64 and NOCFPS of Tk. 1.41 for the year ended on June 30, 2020 as against Tk. 2.02, Tk. 23.12 and Tk. 1.00 respectively for the same period of the previous year.

SILCOPHL 01-Nov-2020

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 1, 2020 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2020.

SILCOPHL 23-Aug-2020

The Company has informed that the Company has signed its first export agreement with ZAID ELYAS ADIL LTD, Afghanistan. The Company will export total of 13 different medicines to Afghanistan for next 5 years commencing from August 2020. Total export value (estimated) will be 3,80,000.00 US Dollar. First export value (as per PI) will be 26,780.00 US Dollar against 13 different medicines to Afghanistan and estimated profit will be 30% against the export.

SILCOPHL 30-Jun-2020

(Q3 Un-audited): EPS was Tk. 0.25 for January-March 2020 as against Tk. 0.41 for January-March 2019; EPS was Tk. 0.76 for July 2019-March 2020 as against Tk. 1.07 for July 2018-March 2019. NOCFPS was Tk. 1.22 for July 2019-March 2020 as against Tk. 0.10 for July 2018-March 2019. NAV per share was Tk. 21.60 as on March 31, 2020 and Tk. 23.12 as on June 30, 2019.

Previous Next page